Literature DB >> 22723041

High-intensity focused ultrasound in obstetrics and gynecology: the birth of a new era of noninvasive surgery?

A Griffiths1, G terHaar2, I Rivens2, D Giussani3, C Lees4.   

Abstract

Although ultrasound is an essential investigative modality in obstetrics and gynecology, the potential for therapeutic high-intensity focused ultrasound (HIFU) (also referred to as focused ultrasound surgery, FUS) to offer an alternative to invasive surgery is less well known. The ability of HIFU to create discrete regions of tissue necrosis only in precisely targeted positions by careful placement of the focus, without the need for any surgical intervention, has made HIFU of interest to those seeking noninvasive alternatives to conventional abdominal surgery. This article reviews the current experimental and clinical experience with HIFU in obstetrics and gynecology, and outlines potential future applications in fetal medicine and the challenges faced in their development. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22723041     DOI: 10.1055/s-0031-1299407

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  3 in total

1.  High-Intensity Focused Ultrasound Ablation of Uterine Fibroids - Potential Impact on Fertility and Pregnancy Outcome.

Authors:  M K Bohlmann; F Hoellen; P Hunold; M David
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-02       Impact factor: 2.915

2.  Natural Size Development of Myomata - Ultrasound Observational Study of 55 Premenopausal Patients.

Authors:  M David; L Adams; J H Stupin
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-01-21       Impact factor: 2.915

Review 3.  Percutaneous High Frequency Microwave Ablation of Uterine Fibroids: Systematic Review.

Authors:  Anna Maria Ierardi; Valeria Savasi; Salvatore Alessio Angileri; Mario Petrillo; Sara Sbaraini; Antonio Pinto; Francesco Hanozet; Anna Maria Marconi; Gianpaolo Carrafiello
Journal:  Biomed Res Int       Date:  2018-01-08       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.